腺苷对猪急性心肌梗死再灌注后内皮素-1的影响

来源 :中国医学科学院学报 | 被引量 : 0次 | 上传用户:yushu522216869
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的评价急性心肌梗死(AMI)再灌注后内皮素-1(ET-1)的变化及腺苷对ET-1的影响,探讨无再流的可能机制。方法中华小型猪24只,随机分成对照组、腺苷组和假手术组,每组8只。冠状动脉结扎3h,松解1h制备AMI再灌注模型。采用放射免疫方法测定AMI前5min、AMI后5min、AMI后180min和再灌注后5min和60min血浆ET-1的含量及正常、缺血、无再流区心肌组织ET-1的变化;逆转录-聚合酶链反应的方法观察正常、缺血和无再流区心肌组织ET-1mRNA的表达。结果与AMI前比较,对照组和腺苷组AMI后5min、AMI后180min、再灌注后5min和60min的血清ET-1水平均显著升高(P<0·01),且呈递增趋势(P<0·01)。腺苷组除AMI前外,各时间点的血浆ET-1水平均显著低于对照组(P<0·05,P<0·01)。与正常区心肌组织比较,对照组和腺苷组缺血区和无再流区心肌组织ET-1含量均显著升高(P<0·01),且无再流区ET-1含量升高比缺血区更显著(P<0·01)。与对照组比较,腺苷组仅缺血区心肌组织ET-1含量显著降低(P<0·01)。与正常区心肌组织比较,对照组和腺苷组缺血区心肌组织ET-1的mRNA表达均显著上调(P<0·01),而无再流区心肌组织ET-1的mRNA表达均显著下降(P<0·01)。与对照组比较,腺苷组仅在缺血区ET-1的mRNA表达显著降低(P<0·01)。结论内皮细胞受损可能是无再流发生的重要机制之一,腺苷可能通过保护内皮细胞起到减少无再流的作用。 Objective To evaluate the changes of endothelin-1 (ET-1) and the effect of adenosine on ET-1 after acute myocardial infarction (AMI) reperfusion in rats and to explore the possible mechanism of no-reflow. Methods Twenty-four Chinese miniature pigs were randomly divided into control group, adenosine group and sham operation group, with 8 in each group. Coronary artery ligation 3h, release 1h prepared AMI reperfusion model. Radioimmunoassay was used to determine the plasma levels of ET-1 at 5 min before AMI, 5 min after AMI, 180 min after AMI, 5 min and 60 min after reperfusion, and the changes of ET-1 in normal, ischemic and non-reflow myocardium. Polymerase chain reaction method was used to observe the expression of ET-1mRNA in normal, ischemic and non-reflow myocardium. Results Compared with those before AMI, ET-1 levels in control group and adenosine group were significantly increased at 5 min after AMI, 180 min after AMI, 5 min and 60 min after reperfusion (P <0.01), and showed an increasing trend (P <0 · 01). In addition to AMI, adenosine group plasma ET-1 levels were significantly lower than the control group (P <0.05, P <0.01). Compared with normal myocardium, the content of ET-1 in myocardium of ischemic area and no-reflow area of ​​control group and adenosine group were significantly increased (P <0.01), and there was no increase of ET-1 in reflowed area More significantly than the ischemic area (P <0.01). Compared with the control group, the content of ET-1 in the adenosine group was significantly decreased only in the ischemic myocardium (P <0.01). Compared with the normal myocardium, the mRNA expression of ET-1 in the ischemic myocardium of control group and adenosine group was significantly increased (P <0.01), while the mRNA expression of ET-1 in the non-reflow myocardium was significantly increased Decreased (P <0.01). Compared with the control group, the expression of ET-1 mRNA in adenosine group was significantly decreased only in ischemic area (P <0.01). Conclusions Endothelial cell damage may be one of the important mechanisms of no-reflow. Adenosine may play a role in reducing no-reflow by protecting endothelial cells.
其他文献
目的探讨小儿MP感染的临床特点。方法采用ELISA法检测血MP-IgM,对确诊为MP感染的121例住院患儿资料进行回顾性分析。结果小儿MP感染临床表现多样,除呼吸道症状外,还可有肺外
2017年底,国家宣布全国所有公立医院全面取消药品加成,并且强调药学工作要向药学服务方向发展.同时“二胎政策”出台,围孕期人群的用药咨询需求日益增加,因此本文基于目前围
目的探讨以脑缺血为主要症状的主动脉弓上血管狭窄性病变的介入治疗效果。方法52例患者的共56处主动脉弓上狭窄性病变接受了血管腔内治疗,其中锁骨下动脉狭窄22处,锁骨下动脉
目的:探讨中医治疗骨折愈合迟缓临床效果观察.方法对82例骨折愈合迟缓患者基础资料收集整合并纳入研究对象,参照区组随机设计原则划分本组患者为两组,即对参照组41例、研究组
<正>尊敬的医师:目前,我国脑卒中呈现出高发病率、高致残率、高死亡率、高复发率、高经济负担5大特点,其发病率正以每年8.7%的速度上升,已成为居民的第1位死亡原因。面对脑卒
抗菌药物的广泛应用极大地增强了人类治疗感染性疾病的能力,但随之而来的耐药、过敏、菌群失调等又使其成为潜在危害.因此,合理使用抗菌药物,做好药品不良反应(ADR)监测至关
目的:对中药鉴定的要点与知识进行分析与探讨,总结经验与知识,确保中药质量,更好的为临床服务.方法:概括总结长期的工作经验和理论知识,使能了解性状鉴定的内容与要求,熟悉中
观察血府逐血汤联合西药治疗椎间孔后血肿压迫下肢疼痛的临床疗效.选择腰椎间盘突出症患者为研究对象,随机分为对照组和观察组.对照组常规给予脱水,肿胀和抗炎治疗.视力评分V